News
TipRanks on MSN5h
UBS Reiterates Buy Rating on Eli Lilly Stock (LLY) as Weight-Loss Drug Sales AccelerateUBS has reiterated its Buy rating and $1,050 price target on LLY stock, highlighting the company’s growing dominance in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback